Biomarkers for cervical myelopathy
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study is looking at biomarkers (biological signs in the body) that could help diagnose and understand cervical spondylotic myelopathy (CSM), a condition where the spinal cord in the neck gets compressed. It involves both people with CSM and healthy volunteers to compare their blood or imaging data, which may lead to better detection and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You either have cervical spondylotic myelopathy (a condition where the spine narrows and presses on the spinal cord in the neck) or you are a healthy person with no neck problems.
- You have not had surgery on your neck before.
- You do not have a history of cancer, a recent injury (within 6 months), or an active infection.
- For those with CSM, your scans (MRI/CT) show that the narrowing is the cause, not another condition like a tumor or inflammation.
- For healthy volunteers, you have no neck pain, numbness, or weakness in your arms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at MRI scans of people with neck pain caused by nerve irritation to see if there are any changes in the spinal cord. It may help doctors better understand and treat this condition.
This study follows adults with spinal cord compression in the neck caused by wear and tear changes. It aims to understand the condition better and may help guide future treatment.
This trial builds a “repository,” or database, of people with a neck-spine condition. It aims to better understand degenerative problems in the neck that may or may not be causing spinal cord symptoms, which could help future research and care.
This study follows adults with degenerative narrowing in the neck spine to see how symptoms and function change over time. It may help doctors better understand which patients improve or worsen, and why.
This trial studies whether certain inflammatory biomarkers in blood and spinal fluid can help diagnose autoimmune diseases affecting the brain and spinal cord. It may help people who are undergoing testing for white matter lesions.
This study is looking for people with a spinal cord injury from a blunt force (not a penetrating injury like a gunshot or stab wound) to see if certain substances in the blood (called biomarkers) can help doctors understand the injury better and predict recovery. It involves an initial blood sample within 24 hours of the injury and follow-up assessments.
Hear when a new Cervical Spondylotic Myelopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.